The merger will bring together brands such as Huggies, Kleenex, Aveeno, and Tylenol, with Kimberly-Clark shareholders set to ...

Yacktman Asset Management's Q3 2025 13F portfolio value declined to $7.26B, with 70 holdings and ~9% cash. Learn more about ...

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

In other news, Apple suppliers Qorvo and Skyworks plan to combine and metal card maker Composecure offers a bid for Husky ...

Stocks fell on Wall Street, pulled down by losses in the same big tech companies that have been the main drivers of the ...

A number of prominent hedge funds are likely applauding Monday’s news that Kimberly-Clark Corp. has agreed to acquire Kenvue ...

AM ET, the S&P 500 gained 10.83 points, or 0.16%, the Nasdaq Composite gained 119.50 points, or 0.51%, and the Dow Jones ...

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Evercore also said Kimberly’s move expands its footprint into two stable, cash-generative global categories, personal hygiene and consumer health, that have high barriers to entry and rational pricing ...

Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...